User menu

Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study.

Bibliographic reference Faivre, S ; Niccoli, P ; Castellano, D ; Valle, J W ; Hammel, P ; et. al. Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study.. In: Annals of Oncology, Vol. epub head of print, no.epub ahead of print, p. mdw561 (2016)
Permanent URL http://hdl.handle.net/2078.1/180140